Fludrocortisone vs placebo
Blood pressure · people with diabetes and orthostatic hypotension
1 finding from 1 review
- no estimate extracted1 study · 6 participantsVery low
Findings
What do systematic reviews say?
13 questions · 13 findings · 2 reviews
No studies found 5 · 38.5%GRADE not reported 3 · 23.1%Very low 5 · 38.5%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Fludrocortisone vs placebo
Orthostatic symptoms · people with diabetes and orthostatic hypotension
1 finding from 1 review
- no estimate extracted1 study · 6 participantsVery low
Fludrocortisone vs placebo
Frequency and severity of postural lightheadedness · people with diabetes and orthostatic hypotension
1 finding from 1 review
- no estimate extracted0 participantsGRADE not reported
Fludrocortisone vs placebo
Frequency of syncope · people with diabetes and orthostatic hypotension
1 finding from 1 review
- no estimate extracted0 participantsGRADE not reported
Fludrocortisone vs placebo
Quality of life · people with diabetes and orthostatic hypotension
1 finding from 1 review
- no estimate extracted0 participantsGRADE not reported
Fludrocortisone vs placebo
Serious or severe adverse events · people with diabetes and orthostatic hypotension
1 finding from 1 review
- no estimate extracted1 study · 6 participantsVery low
HC (15 mg/m²/day) vs HC (25 mg/m²/day) with fludrocortisone (0.1 mg/day)
QoL · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
- Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
HC (15 mg/m²/day) vs HC (25 mg/m²/day) with fludrocortisone (0.1 mg/day)
Androgen normalisation · people with CAH
1 finding from 1 review
- Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia 2020 · Cochrane Headline outcomes onlyno estimate extracted26 participantsVery low
HC (15 mg/m²/day) vs HC (25 mg/m²/day) with fludrocortisone (0.1 mg/day)
Prevention of adrenal crisis · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
- Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
HC (15 mg/m²/day) vs HC (25 mg/m²/day) with fludrocortisone (0.1 mg/day)
Presence of osteopenia · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
- Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
HC (15 mg/m²/day) vs HC (25 mg/m²/day) with fludrocortisone (0.1 mg/day)
Presence of testicular or ovarian adrenal rest tumours · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
- Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
HC (15 mg/m²/day) vs HC (25 mg/m²/day) with fludrocortisone (0.1 mg/day)
Subfertility · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
- Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
HC (15 mg/m²/day) vs HC (25 mg/m²/day) with fludrocortisone (0.1 mg/day)
Final adult height · people with CAH
1 finding from 1 review
- Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia 2020 · Cochrane Headline outcomes onlyno estimate extracted26 participantsVery low